Qinyuan Zhu

Qinyuan Zhu

Auto-generated profile, based on publicly available information

Qinyuan Zhu

Department of Dermatology Huashan Hospital Fudan University Shanghai China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in Oncogene
Verified
Journal Article
Open access
PDF file
WCWeifeng Chen
Weifeng Chen
YJYuhang Jiang
Yuhang Jiang
JZJun Zeng
Jun Zeng
DLDandan Liu
Dandan Liu
XFXiaoting Feng
Xiaoting Feng
QWQi Wang
Qi Wang
Diffuse large B-cell lymphoma (DLBCL) remains a major clinical challenge and requires the development of new therapeutic approaches. The identification of cuproptosis, a newly defined form of copper-induced cell death, has provided innovative insights for cancer therapy. Here, we report that loss of the mitochondrial matrix reductase FDX1 in DLBCL cells impairs the antitumor effect of elesclomol (ES), which performs its function by transporting excess copper into cells. Overexpressing (OE) FDX1 significantly sensitized DLBCL cells to ES-induced cell death in vitro and enhanced the anticancer activity of ES in vivo. Furthermore, treatment with ES in FDX1-high expression patient-derived xenograft (PDX) showed a significantly greater inhibitory effect than in FDX1-low expression PDX. Mechanistically, FDX1 promotes the induction of IFN-β-dependent PANoptosis by increasing IRF3 phosphorylation in DLBCL cells upon ES treatment. Consistent with this finding, patient cohort analysis revealed that FDX1 expression correlated positively with enhanced IRF3 phosphorylation. Together, our findings are the first to identify the central role of FDX1 in synergizing with ES to activate IFN-β signaling and induce PANoptosis. This study enables us to re-explore the clinical anticancer potential of ES as a novel therapeutic strategy for DLBCL.

1 January 2023 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
YSYangbai Sun
Yangbai Sun
XLXuesi Liu
Xuesi Liu
QYQingrong Ye
Qingrong Ye
QZQinyuan Zhu
Qinyuan Zhu
CWChunmeng Wang
Chunmeng Wang
WYWangjun Yan
Wangjun Yan
Original Article Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up? Yangbai Sun, Xuesi Liu, Qingrong Ye, Qinyuan Zhu, Chunmeng Wang, Wangjun Yan

5 October 2026 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Closed access
QWQian Wang
Qian Wang
ZLZiQi Liu
ZiQi Liu
SJShangLin Jin
ShangLin Jin
XHXiaoMu Hu
XiaoMu Hu
QSQianWen Shen
QianWen Shen
QZQinYuan Zhu
QinYuan Zhu

1 January 2026 in Analytical Cellular Pathology
Verified
Journal Article
Open access
PDF file
YSYangbai Sun
Yangbai Sun
QZQinyuan Zhu
Qinyuan Zhu
CYChaoran Yu
Chaoran Yu
CWChunmeng Wang
Chunmeng Wang
WYWangjun Yan
Wangjun Yan
CJChaoyin Jiang
Chaoyin Jiang
Background: Heterotopic ossification (HO) represents a highly active research field in pathological bone formation. Despite substantial advancements, a comprehensive understanding of its underlying mechanisms and clinical trajectory remains incomplete. Materials and Methods: A bibliometric and machine‐learning latent Dirichlet allocation (LDA) analysis was performed using data retrieved from the Web of Science Core Collection database. Results: A total of 4722 publications related to HO were identified. The most prolific countries included the USA, CHINA, GERMANY, the UK, JAPAN, SOUTH KOREA, ITALY, TURKEY, FRANCE, and CANADA . GERMANY demonstrated the highest citation strength, followed by CHINA . Aside from “heterotopic ossification,” other frequently occurring author keywords included “fibrodysplasia ossificans progressive,” “complications” and “total hip arthroplasty.” In keywords plus, besides HO, replacement, bone‐formation, and arthroplasty were the most frequently occurring terms. Institutional network analysis with subject‐specific clustering indicated that Shanghai Jiao Tong University was significantly enriched in radiology, nuclear medicine and medical imaging, while Wilderness Spine Serv specialized in surgical management. A developmental timeline plot of a network of most contributing authors also was visualized, along with the most influential references. Meanwhile, citation analysis indicated that Kaplan FS and Shore EM were the top‐cited authors. By LDA analysis, a total of 16 key topics were identified in this field with distinct period‐proportion visualization. One of the topics, cell bone express differentiation and formation has clearly dominated the last 10 years. Conclusion: This study constitutes the most extensive text processing analysis of HO to date, offering valuable insights and directions for future development.

6 March 2026 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Closed access
QWQian Wang
Qian Wang
ZLZiQi Liu
ZiQi Liu
SJShangLin Jin
ShangLin Jin
XHXiaoMu Hu
XiaoMu Hu
QSQianWen Shen
QianWen Shen
QZQinYuan Zhu
QinYuan Zhu

22 November 2024 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
QZQinyuan Zhu
Qinyuan Zhu
HCHuyan Chen
Huyan Chen
JLJing Luan
Jing Luan
QHQiong Huang
Qiong Huang
LCLianjun Chen
Lianjun Chen
SCShujun Chen
Shujun Chen
While 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) is widely used to treat actinic keratosis (AK), treatment resistance and recurrence after ALA-PDT remain clinical challenges. This single-site, retrospective, matched case-control study included 119 patients with histologically confirmed AK to identify clinical and pathological predictors for effectiveness of ALA-PDT. Patients received four consecutive ALA-PDT sessions at intervals of 1 or 2 weeks. Initial complete clearance (ICC) at 3 months and sustained complete clearance (SCC) at 12 months were assessed. Case patients were those with treatment-resistant or recurrent AK, matched with controls based on age, sex, and the treatment date. Baseline characteristics were collected and compared between the case and control groups. ICC at 3 months was achieved in 106 out of 119 patients (89.07%), with 65 out of 82 patients (79.27%) maintaining SCC at 12 months. Pigmented AK emerged as an independent predictor of treatment resistance (OR=44.05, p=0.00). Furthermore, follicular extension to the isthmus or deeper was significantly associated with recurrence within 1 year (OR=17.26, p=0.00). Pigmented AK and AK with follicular extension to the isthmus or deeper may serve as independent predictors of treatment resistance and recurrence, respectively. These findings highlight the importance of these specific features when assessing prognosis and tailoring treatment strategies for individual AK patients.